Platin-A

Platin-A is an experimental platinum-based anticancer agent described in the preclinical literature as a nanoparticle or nanoformulation designed to deliver a cisplatin-like platinum payload more selectively to tumors, aiming to retain the DNA‑damaging efficacy of classical platinum drugs such as cisplatin while improving pharmacokinetics and reducing systemic toxicity. Mechanistically, Platin-A is intended to enter cancer cells and release active platinum species that form intra- and inter-strand DNA crosslinks, thereby blocking DNA replication and transcription and inducing cell-cycle arrest and apoptosis. It is being investigated primarily in oncology settings and, based on available information, remains in early, non‑clinical development without established human indications or regulatory approvals.

Other names

human serum albumin-platinum complexHSA-Pt agentHSA–Pt(Dp44mT) nanoparticle